This is not the most recent version of the article. View current version (5 MAY 2015)

Intervention Protocol

Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease

  1. Jan C Preiss1,*,
  2. Antje Timmer2

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD007572


How to Cite

Preiss JC, Timmer A. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007572. DOI: 10.1002/14651858.CD007572.

Author Information

  1. 1

    Charité - Universitätsmedizin Berlin, Med. Klinik I, Berlin, Germany

  2. 2

    German Cochrane Center, Department of Medical Biometry and Statistics, Freiburg, Germany

*Jan C Preiss, Med. Klinik I, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, 12203, Germany. jan.preiss@charite.de.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

This is not the most recent version of the article. View current version (05 MAY 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy and safety of IL-12/23p40-antibodies for induction of remission in Crohn's disease.